# Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT

> **NCT02638051** · PHASE2 · COMPLETED · sponsor: **Galenic Research Institute Ltd** · enrollment: 260 (actual)

## Conditions studied

- Peritoneal Neoplasms
- Ascites
- Yang Deficiency
- Yin Deficiency

## Interventions

- **DEVICE:** Modulated Electro-Hyperthermia (mEHT)
- **DIETARY_SUPPLEMENT:** TCM Herbal Decoction (Shi Pi)
- **DRUG:** IPCI (CDDP+5FU)

## Key facts

- **NCT ID:** NCT02638051
- **Lead sponsor:** Galenic Research Institute Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02638051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02638051, "Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02638051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*